4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000189
Chairperson & CEO sold 9,500 shares at an average $592.42 ($5,627,991)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-11-13 | Sale : show line 2 in the form 10b5-1 | −528 | $587.42 | $310,156 | 333,415 | I |
| 2026-11-13 | Sale : show line 3 in the form 10b5-1 | −493 | $588.61 | $290,183 | 332,922 | I |
| 2026-11-13 | Sale : show line 4 in the form 10b5-1 | −603 | $589.80 | $355,647 | 332,319 | I |
| 2026-11-13 | Sale : show line 5 in the form 10b5-1 | −1,657 | $590.65 | $978,702 | 330,662 | I |
| 2026-11-13 | Sale : show line 6 in the form 10b5-1 | −2,181 | $591.56 | $1,290,198 | 328,481 | I |
| 2026-11-13 | Sale : show line 7 in the form 10b5-1 | −518 | $592.61 | $306,973 | 327,963 | I |
| 2026-11-13 | Sale : show line 8 in the form 10b5-1 | −245 | $593.81 | $145,483 | 327,718 | I |
| Open-market sales · 9,500 sh · avg $592.42 · $5,627,991 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-13 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Option | −9,500 | 24,410 | I |
Loading xslF345X06/primarydocument.xml…